SCHEMBL24282111

SCHEMBL24282111

COc1cc2n(c(=O)n1)CCc1cc(OCC3CCOCC3)ccc1-2

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15826219 0.93 GPR84 (0.74) GPR84
SCHEMBL19337553 0.85 GPR84 (0.73) GPR84
SCHEMBL15050913 0.85 GPR84 (1.00) GPR84
SCHEMBL15050914 0.85 GPR84 (1.00) GPR84
SCHEMBL20621105 0.85 GPR84 (1.00) GPR84
SCHEMBL29783364 0.85 GPR84 (1.00) GPR84
SCHEMBL19337556 0.83 GPR84 (0.69) GPR84
SCHEMBL15050939 0.81 GPR84 (1.00) GPR84
SCHEMBL15050940 0.81 GPR84 (1.00) GPR84
SCHEMBL15826276 0.81 GPR84 (1.00) GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3378862-B1 DIHYDROPYRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF MULTIPLE SCLEROSIS GALAPAGOS NV (BE) 2022-03-16 EP disclosed